Whole Brain Radiotherapy (WBRT) With Sorafenib for Breast Cancer Brain Metastases (BCBM)
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Breast Cancer|Brain Metastases
Interventions: RADIATION: Whole Brain Radiotherapy (WBRT)|DRUG: Sorafenib
Sponsor: Memorial Sloan Kettering Cancer Center
Collaborators: Bayer